Skip to content

Visual Outcomes and Patient Satisfaction With Implantation of the Clareon Monofocal IOL With the New Clareon Manual Monarch IV IOL Delivery System

Visual Outcomes and Patient Satisfaction With Implantation of the Clareon Monofocal IOL With the New Clareon Manual Monarch IV IOL Delivery System

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05526781
Enrollment
34
Registered
2022-09-02
Start date
2022-09-21
Completion date
2024-03-12
Last updated
2025-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Brief summary

To evaluate visual outcomes, in-the-bag placement and patient satisfaction in patients implanted with either Clareon monofocal or Clareon monofocal toric IOLs with the Monarch IV inserter and targeted for emmetropia.

Detailed description

This study is a single-arm clinical evaluation study of visual performance and patient satisfaction, after successful bilateral cataract surgery. Subjects will be assessed pre- operatively, operatively and at 1 month and 3 months post-operatively. Clinical evaluations will include measurement of bilateral visual acuity, manifest refraction, and IOLSAT questionnaire.

Interventions

DEVICEClareon monofocal Intraocular lens (toric and non-toric models)

Bilateral implantation of the Clareon monofocal Intraocular lens (toric and non-toric models) with the Monarch IV inserter

Sponsors

Sengi
CollaboratorINDUSTRY
Eye Consultants of Atlanta
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum

Inclusion criteria

Subjects are eligible for the study if they meet the following criteria: Note: Ocular criteria must be met in both eyes. * Adult cataract surgical patients over the age of 45 with visually significant bilateral cataracts (glare visual acuity 20/40 or worse with BCVA testing), with planned cataract extraction using phacoemulsification, clear corneal incision and Clareon monofocal or Clareon toric with Monarch IV. * Able to provide written informed consent for participation in the study. * All eyes will be in the range of availability for Clareon monofocal and Clareon toric with Monarch IV. * Expected visual potential of 20/25 Snellen (0.10 logMAR) or better in each eye.

Exclusion criteria

If any of the following

Design outcomes

Primary

MeasureTime frame
Monocular Corrected Distance Visual Acuity (6m)3 months postoperative
Binocular Uncorrected Distance Visual Acuity (6m)3 months postoperative
Binocular Corrected Distance Visual Acuity (6m)3 months postoperative
Monocular Uncorrected Distance Visual Acuity (6m)3 months postoperative

Secondary

MeasureTime frameDescription
Monocular Uncorrected Intermediate Visual Acuity (66cm)3 months postoperative
Binocular Uncorrected Intermediate Visual Acuity (66cm)3 months postoperative
Binocular Distance Corrected Intermediate Visual Acuity (66cm)3 months postoperative
Monocular Distance Corrected Intermediate Visual Acuity (66cm)3 months postoperative
Manifest Refraction Spherical Equivalent (MRSE)3 months postoperativeThe percentage of eyes with MRSE within ± 0.5 D.
Overall Surgeon Satisfaction of Monarch IV Delivery ExperienceOperative visit (Day 0)Score from 1-5. Higher scores indicate high surgeon satisfaction. Satisfaction was determined as the percentages of eyes where the surgeon was Satisfied or Very Satisfied.
Consistency of In-the-bag Delivery of IOL During Implantation With Monarch IVOperative visit (Day 0)Score from 1-4. Higher scores indicate higher consistency. Outcome measure is the percentage of eyes where the IOL from cartridge coming out as planar, able to deliver IOL easily and smoothly into capsular bag.

Countries

United States

Participant flow

Participants by arm

ArmCount
Clareon® Monofocal Intraocular Lens (Toric and Non-toric Models)
Bilateral implantation of the Clareon monofocal Intraocular lens (toric and non-toric models) with the Monarch IV inserter Clareon monofocal Intraocular lens (toric and non-toric models): Bilateral implantation of the Clareon monofocal Intraocular lens (toric and non-toric models) with the Monarch IV inserter
28
Total28

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up1

Baseline characteristics

CharacteristicClareon® Monofocal Intraocular Lens (Toric and Non-toric Models)
Age, Continuous69.6 years
STANDARD_DEVIATION 6.8
Race and Ethnicity Not Collected— Participants
Sex/Gender, Customized
Sex
Female
13 Participants
Sex/Gender, Customized
Sex
Male
13 Participants
Sex/Gender, Customized
Sex
Not Disclosed
2 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 28
other
Total, other adverse events
0 / 28
serious
Total, serious adverse events
0 / 28

Outcome results

Primary

Binocular Corrected Distance Visual Acuity (6m)

Time frame: 3 months postoperative

ArmMeasureValue (MEAN)Dispersion
Clareon® Monofocal Intraocular Lens (Toric and Non-toric Models)Binocular Corrected Distance Visual Acuity (6m)0.00 logMARStandard Deviation 0.02
Primary

Binocular Uncorrected Distance Visual Acuity (6m)

Time frame: 3 months postoperative

ArmMeasureValue (MEAN)Dispersion
Clareon® Monofocal Intraocular Lens (Toric and Non-toric Models)Binocular Uncorrected Distance Visual Acuity (6m)0.03 logMARStandard Deviation 0.04
Primary

Monocular Corrected Distance Visual Acuity (6m)

Time frame: 3 months postoperative

ArmMeasureValue (MEAN)Dispersion
Clareon® Monofocal Intraocular Lens (Toric and Non-toric Models)Monocular Corrected Distance Visual Acuity (6m)0.00 logMARStandard Deviation 0.02
Primary

Monocular Uncorrected Distance Visual Acuity (6m)

Time frame: 3 months postoperative

ArmMeasureValue (MEAN)Dispersion
Clareon® Monofocal Intraocular Lens (Toric and Non-toric Models)Monocular Uncorrected Distance Visual Acuity (6m)0.06 logMARStandard Deviation 0.07
Secondary

Binocular Distance Corrected Intermediate Visual Acuity (66cm)

Time frame: 3 months postoperative

ArmMeasureValue (MEAN)Dispersion
Clareon® Monofocal Intraocular Lens (Toric and Non-toric Models)Binocular Distance Corrected Intermediate Visual Acuity (66cm)0.0 logMARStandard Deviation 0.05
Secondary

Binocular Uncorrected Intermediate Visual Acuity (66cm)

Time frame: 3 months postoperative

ArmMeasureValue (MEAN)Dispersion
Clareon® Monofocal Intraocular Lens (Toric and Non-toric Models)Binocular Uncorrected Intermediate Visual Acuity (66cm)0.09 logMARStandard Deviation 0.05
Secondary

Consistency of In-the-bag Delivery of IOL During Implantation With Monarch IV

Score from 1-4. Higher scores indicate higher consistency. Outcome measure is the percentage of eyes where the IOL from cartridge coming out as planar, able to deliver IOL easily and smoothly into capsular bag.

Time frame: Operative visit (Day 0)

ArmMeasureValue (COUNT_OF_UNITS)
Clareon® Monofocal Intraocular Lens (Toric and Non-toric Models)Consistency of In-the-bag Delivery of IOL During Implantation With Monarch IV50 eyes
Secondary

Manifest Refraction Spherical Equivalent (MRSE)

The percentage of eyes with MRSE within ± 0.5 D.

Time frame: 3 months postoperative

ArmMeasureValue (COUNT_OF_UNITS)
Clareon® Monofocal Intraocular Lens (Toric and Non-toric Models)Manifest Refraction Spherical Equivalent (MRSE)51 eyes
Secondary

Monocular Distance Corrected Intermediate Visual Acuity (66cm)

Time frame: 3 months postoperative

ArmMeasureValue (MEAN)Dispersion
Clareon® Monofocal Intraocular Lens (Toric and Non-toric Models)Monocular Distance Corrected Intermediate Visual Acuity (66cm)0.05 logMARStandard Deviation 0.05
Secondary

Monocular Uncorrected Intermediate Visual Acuity (66cm)

Time frame: 3 months postoperative

ArmMeasureValue (MEAN)Dispersion
Clareon® Monofocal Intraocular Lens (Toric and Non-toric Models)Monocular Uncorrected Intermediate Visual Acuity (66cm)0.12 logMARStandard Deviation 0.05
Secondary

Overall Surgeon Satisfaction of Monarch IV Delivery Experience

Score from 1-5. Higher scores indicate high surgeon satisfaction. Satisfaction was determined as the percentages of eyes where the surgeon was Satisfied or Very Satisfied.

Time frame: Operative visit (Day 0)

ArmMeasureValue (COUNT_OF_UNITS)
Clareon® Monofocal Intraocular Lens (Toric and Non-toric Models)Overall Surgeon Satisfaction of Monarch IV Delivery Experience56 eyes

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026